The UK government announces £12.6 million in funding to support farming innovation, including robotic harvesters and livestock health monitoring systems, through two new competitions.
Afon Technology is pioneering advancements in diabetes care with its innovative device, Glucowear™, which is being developed as the world’s first non-invasive, real-time, continuous blood glucose monitor.
A new semiconductor inspection and metrology platform, developed through a collaboration between Nagoya University and its startup, Photoelectron Soul Inc. (PeS), is set to begin validation in KIOXIA’s advanced production lines.
Using data from NASA’s PACE ocean satellite, scientists are mapping plant productivity worldwide, offering new insights into ecosystem health and climate impacts.
A Harvard study finds that following a Mediterranean diet can lower dementia risk for those with high genetic susceptibility, including APOE4 carriers.
The University of Oxford has launched a £118M AI vaccine research programme, CoI-AI, with the Ellison Institute, aiming to combat antibiotic resistance through human challenge trials.
Professor Susanna Price, Chair of the European Society of Cardiology’s Advocacy Committee, advocates for improved early detection and addressing inequalities in cardiovascular disease prevention, the leading cause of death worldwide.
Tandem Health’s AI medical assistant is helping thousands of clinicians alleviate the burden of documentation, enabling them to reclaim their time and reduce stress.
With Europe’s climate continuing to change, the summer of 2022 was the hottest ever recorded on the continent. It brought intense heatwaves, wildfires, and severe droughts. Rivers dried up, crops withered, and ecosystems suffered.
Accuro offers speech-to-text transcription services designed to alleviate the administrative burden faced by clinicians in healthcare settings. Here, they explain the advantages of the company’s Ambient Voice Technology (AVT), particularly through the use of an Ambient Scribe.
Good policy builds on reliable science. Bernard Magenhann, Director-General of the Joint Research Centre (JRC), points out that investing in research at the EU level means supporting independent science to inform policymaking and, by extension, standards and norms that affect our daily lives.
